Gara Jalqabaatti › Dhibee Gaddii Guddaa › Missouri
Qorannoo klinikaalii Dhibee Gaddii Guddaa Missouri keessatti
Qorannoo 16 Dhibee Gaddii Guddaa f Missouri keessatti hirmaatuu jiru.
Magaalota Missouri keessatti
Takkalaa qorannoo (Ingiliffa)
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- St. Charles Psychiatric Associates, Inc. dba Midwest Research Group, Saint Charles
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07284667A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Arch Clinical Trials, LLC, St Louis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Arch Clinical Trials, St Louis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07412756Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Psychiatric Care and Research Center (PCRC), O'Fallon
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05850689Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Saint Charles
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06830044Lumateperone for Late-Life Depression
- Washington University School of Medicine, St Louis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07623135A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, St Louis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07065240A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Psychiatric Care and Research Center, O'Fallon
- St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07076407Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Washington University School of Medicine, St Louis
Namoota walitti qabaa jira
Umuriin 22 hanga 70 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT06423430A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Tekton Research, St Louis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, O'Fallon
- Neurocrine Clinical Site, Saint Charles
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT06966401A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, O'Fallon
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07196501A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Midwest Research Group, Saint Charles
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT06524830NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits
- Washington University School of Medicine, St Louis
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 29-Elb-2026 · NCT02994433Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #127, Saint Charles
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT06633016A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Saint Charles
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 23-Ama-2025 · NCT06223880Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.